NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ:MRVI). Investors who purchased Maravai securities prior to August 7, 2024, and continue to hold to the present, are encouraged to […]

NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sage Therapeutics, Inc. ("Sage" or "the Company") (NASDAQ:SAGE). Investors who purchased Sage securities prior to April 12, 2021, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA). Investors who purchased Paragon 28 securities prior to May 5, 2023, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equinix, Inc. ("Equinix" or "the Company") (NASDAQ:EQIX). Investors who purchased Equinix securities prior to May 3, 2019, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cummins Inc. ("Cummins" or "the Company") (NYSE: CMI). Investors who purchased Cummins securities prior to April 30, 2019, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EngageSmart, Inc. ("EngageSmart" or "the Company") (NYSE:ESMT). Investors who purchased EngageSmart securities prior to October 23, 2023, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amylyx Pharmaceuticals, Inc. ("Amylyx" or "the Company") (NASDAQ:AMLX). Investors who purchased Amylyx securities prior to November 11, 2022, and continue to hold to the present, are encouraged to obtain

The Edge AI Hardware Market presents significant growth opportunities driven by the demand for real-time processing, semiconductor innovation, and cross-industry AI adoption. However, high deployment costs, integration complexity, and power constraints pose entry barriers. North America's technological leadership and investment climate make it an ideal launchpad for new entrants. Companies targeting this space should focus

NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ:IOVA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

The global Supply Chain Management Market size is projected to grow from USD 38.51 billion in 2025 to USD 58.42 billion by 2030 at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period, according to a new report by MarketsandMarkets™. https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg The increasing complexity of global commerce, along with the growth in